Jenburkt Pharmaceuticals share news, announcements and annual reports
NSE: JENBURPHBSE: 524731Pharmaceuticals & BiotechnologySmall Cap
Jenburkt Pharmaceuticals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1995
Last close ₹853.60down ₹18.70 (2.14%)BSE ₹854.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹872.30.
30 Oct: open ₹887.75, high ₹887.75, low ₹845.10
52-week range of BSE trades to 30 Oct 2026
₹848.35Low, 30 Oct 2026₹1,321.00High, 31 Oct 2025
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹377 Cr1,871st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 11.47
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.95 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 10.24
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.91
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.43%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.95 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 19.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,49687.0% delivered
Jenburkt Pharmaceuticals board meetings
113 filed, newest first. Page 3 of 3.
May 2016
19 May · Board meeting
Meeting of Board of Directors of the Company is scheduled to be held on May 30, 2016, inter alia, to consider: 1. To take on ....
Mar 2016
4 Mar · Board meeting
Meeting of the Board of Directors of the Company will be held on March 10, 2016, inter alia, to consider declaration of interim Dividend, if any. ....
Jul 2015
24 Jul · Board meeting
Board of Directors of the Company at its meeting held on July 24, 2015, inter alia, has transacted the following :- - The Board ....
May 2015
12 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 21, 2015, inter alia to consider: 1. To take on record the ....
May 2014
21 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 30, 2014, inter alia, to consider the following; 1. To take ....
Jul 2013
16 Jul · Board meeting
Board of Directors of the Company at its meeting held on July 16, 2013, has approved the following: 1. Shri. Ashish U. Bhuta ....
May 2013
21 May · Board meeting
Meeting of Board of Directors of the Company will be held on May 30, 2013, inter alia, to consider: 1. To take on record the ....
Feb 2013
Jan 2013
May 2012
18 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 26, 2012, inter alia: 1. To consider and take on record ....
Nov 2011
Jun 2011
17 Jun · Board meeting
Meeting of the Board of Directors of the Company will be held on June 25, 2011, inter alia, to consider the following: 1. To ....
May 2010
21 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 28, 2010, inter alia, to consider and take on record the Audited ....